Impaired vascular function during short-term poor glycaemic control in Type 1 diabetic patients

被引:33
作者
Sorensen, VR
Mathiesen, ER
Clausen, P
Flyvbjerg, A
Feldt-Rasmussen, B
机构
[1] Copenhagen Univ Hosp, Rigshosp, Dept Nephrol, Copenhagen, Denmark
[2] Copenhagen Univ Hosp, Rigshosp, Dept Endocrinol, Copenhagen, Denmark
[3] Aarhus Univ Hosp, Med Dept Diabet & Endocrinol M, Aarhus, Denmark
[4] Aarhus Univ Hosp, Med Res Labs, Aarhus, Denmark
关键词
diabetes mellitus; vascular dysfunction; hyperglycaemia; von Willebrand factor; vascular endothelial growth factor;
D O I
10.1111/j.1464-5491.2005.01543.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim To study the effects of short-term poor glycaemic control on vascular function in Type 1 diabetic patients. Methods Ten Type 1 diabetic patients, with diabetes duration of less than 10 years and normal urinary albumin excretion and ophthalmoscopy, were studied. All patients were examined after 48 h of good vs. poor glycaemic control within a 3-week period. Blood glucose was measured seven times daily for 2 days before each examination. External ultrasound was used to measure the dilatory response of the brachial artery to post-ischaemic increased blood flow (endothelium-dependent dilation) and to nitroglycerin (endothelium-independent dilation). Plasma concentration of von Willebrand factor antigen, adhesion molecules, vascular endothelial growth factor, homocystein and cholesterol were also measured. Results The median blood glucose levels in the 48 h before the examinations were [median (range), good vs. poor control]: 6.3 (5.0-7.6) vs. 15.9 (11.3-17.8) (mmol/l). The flow-associated vasodilation (% of baseline) was reduced during poor control: 102.7 (94.7-110.8) vs. 104.0 (99.6-118.5) (P < 0.05) as were the nitroglycerin-induced dilation (% of baseline): 114.5 (103.3-127.9) vs. 120.2 (106.8-148.0) (P < 0.05). P-von Willebrand factor antigen was high during poor control (kIU/l): 1.14 (0.73-1.84) vs. 0.86 (0.72-1.39) (P < 0.05) and so was P-vascular endothelial growth factor (ng/l): 288 (133-773) vs. 254 (90-383) (P < 0.05). Conclusions Short-term (48 h) hyperglycaemia in Type 1 diabetic patients may disturb vascular function, possibly mediated through smooth muscle cell dysfunction as well as endothelial dysfunction. We suggest that prolonged and repeated episodes of hyperglycaemia could possibly lead to permanent vascular dysfunction and thereby development and progression of vascular complications in diabetes.
引用
收藏
页码:871 / 876
页数:6
相关论文
共 39 条
[1]   INCREASED VASCULAR ENDOTHELIAL GROWTH-FACTOR LEVELS IN THE VITREOUS OF EYES WITH PROLIFERATIVE DIABETIC-RETINOPATHY [J].
ADAMIS, AP ;
MILLER, JW ;
BERNAL, MT ;
DAMICO, DJ ;
FOLKMAN, J ;
YEO, TK ;
YEO, KT .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1994, 118 (04) :445-450
[2]   Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis [J].
Adams, MR ;
Robinson, J ;
McCredie, R ;
Seale, JP ;
Sorensen, KE ;
Deanfield, JE ;
Celermajer, DS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (01) :123-127
[3]   Endothelium-dependent vasodilatation is impaired in both microcirculation and macrocirculation during acute hyperglycemia [J].
Akbari, CM ;
Saouaf, R ;
Barnhill, DF ;
Newman, PA ;
LoGerfo, FW ;
Veves, A .
JOURNAL OF VASCULAR SURGERY, 1998, 28 (04) :687-694
[4]   Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM -: Effect of intensive insulin treatment [J].
Albertini, JP ;
Valensi, P ;
Lormeau, B ;
Aurousseau, MH ;
Ferrière, F ;
Attali, JR ;
Gattegno, L .
DIABETES CARE, 1998, 21 (06) :1008-1013
[5]   The influences of obesity and glycemic control on endothelial activation in patients with type 2 diabetes [J].
Bagg, W ;
Ferri, C ;
Desideri, G ;
Gamble, G ;
Ockelford, P ;
Braatvedt, GD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (11) :5491-5497
[6]  
BLANN AD, 1994, J HYPERTENS, V12, P925
[7]   Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute phase response [J].
Borawski, J ;
Naumnik, B ;
Pawlak, K ;
Mysliwiec, M .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (07) :1442-1447
[8]   Increased circulating intercellular adhesion molecule-1 levels in type II diabetic patients: The possible role of metabolic control and oxidative stress [J].
Ceriello, A ;
Falleti, E ;
Bortolotti, N ;
Motz, E ;
Cavarape, A ;
Russo, A ;
Gonano, F ;
Bartoli, E .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1996, 45 (04) :498-501
[9]   Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus:: The possible role of oxidative stress [J].
Ceriello, A ;
Falleti, E ;
Motz, E ;
Taboga, C ;
Tonutti, L ;
Ézsol, Z ;
Gonano, F ;
Bartoli, E .
HORMONE AND METABOLIC RESEARCH, 1998, 30 (03) :146-149
[10]   Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications [J].
Chiarelli, F ;
Spagnoli, A ;
Basciani, F ;
Tumini, S ;
Mezzetti, A ;
Cipollone, F ;
Cuccurullo, F ;
Morgese, G ;
Verrotti, A .
DIABETIC MEDICINE, 2000, 17 (09) :650-656